The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Anti-cancer peptides: classification, mechanism of action, reconstruction and modification
Open accessAbstract
Anti-cancer peptides (ACPs) are a series of short peptides composed of 10–60 amino acids that can inhibit tumour cell proliferation or migration, or suppress the formation of tumour blood vessels, and are less likely to cause drug resistance. The aforementioned merits make ACPs the most promising anti-cancer candidate. However, ACPs may be degraded by proteases, or result in cytotoxicity in many cases. To overcome these drawbacks, a plethora of research has focused on reconstruction or modification of ACPs to improve their anti-cancer activity, while reducing their cytotoxicity. The modification of ACPs mainly includes main chain reconstruction and side chain modification. After summarizing the classification and mechanism of action of ACPs, this paper focuses on recent development and progress about their reconstruction and modification. The information collected here may provide some ideas for further research on ACPs, in particular their modification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
APD3: the antimicrobial peptide database as a tool for research and education
Wang, G., Li, X., & Wang, Z. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1278 · Cited by 2,388
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Identification of the bactericidal domain of lactoferrin
Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., & Tomita, M. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90346-f · Cited by 892
Role of Peptide Hydrophobicity in the Mechanism of Action of α-Helical Antimicrobial Peptides
Chen, Y., Guarnieri, M. T., Vasil, A. I., Vasil, M. L., Mant, C. T., & Hodges, R. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00925-06 · Cited by 757
Pouny, Y., Rapaport, D., Mor, A., Nicolas, P., & Shai, Y. (1992) · Biochemistry · doi:10.1021/bi00164a017 · Cited by 687
Chen, Y., Mant, C. T., Farmer, S. W., Hancock, R. E. W., Vasil, M. L., & Hodges, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413406200 · Cited by 600
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
Saharinen, P., Eklund, L., Pulkki, K., Bono, P., & Alitalo, K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.015 · Cited by 478
Li, Y., Xiang, Q., Zhang, Q., Huang, Y., & Su, Z. (2012) · Peptides · doi:10.1016/j.peptides.2012.07.001 · Cited by 462
Strasser, R. (2016) · Glycobiology · doi:10.1093/glycob/cww023 · Cited by 453
PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
Milla, P., Dosio, F., & Cattel, L. (2012) · Current Drug Metabolism · doi:10.2174/138920012798356934 · Cited by 419
Electrically gated ionic channels in lipid bilayers
Ehrenstein, G., & Lecar, H. (1977) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500000123 · Cited by 393
Protein palmitoylation and subcellular trafficking
Aicart-Ramos, C., Valero, R. A., & Rodriguez-Crespo, I. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.009 · Cited by 372
Advances in PEGylation of important biotech molecules: delivery aspects
Ryan, S. M., Mantovani, G., Wang, X., Haddleton, D. M., & Brayden, D. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.4.371 · Cited by 323
Yu, W.-D., Sun, G., Li, J., Xu, J., & Wang, X. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.048 · Cited by 308
Inducible Antibacterial Defence System in Drosophila
BOMAN, H. G., NILSSON, I., & RASMUSON, B. (1972) · Nature · doi:10.1038/237232a0 · Cited by 305
The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
J. Boohaker, R., W. Lee, M., Vishnubhotla, P., M. Perez, J. L., & R. Khaled, A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801661004 · Cited by 302
Peptides in cancer nanomedicine: Drug carriers, targeting ligands and protease substrates
Zhang, X.-X., Eden, H. S., & Chen, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.023 · Cited by 243
Antitumor Activity of the Antimicrobial Peptide Magainin II against Bladder Cancer Cell Lines
Lehmann, J., Retz, M., Sidhu, S. S., Suttmann, H., Sell, M., Paulsen, F., Harder, J., Unteregger, G., & Stöckle, M. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.043 · Cited by 228
Cholesterol biosensors: A review
Narwal, V., Deswal, R., Batra, B., Kalra, V., Hooda, R., Sharma, M., & Rana, J. S. (2019) · Steroids · doi:10.1016/j.steroids.2018.12.003 · Cited by 191
Avrahami, D., & Shai, Y. (2002) · Biochemistry · doi:10.1021/bi011549t · Cited by 177
Targeting apoptotic and autophagic pathways for cancer therapeutics
Liu, J.-J., Lin, M., Yu, J.-Y., Liu, B., & Bao, J.-K. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.001 · Cited by 170
Membrane fluidity characteristics of human lung cancer
Sok, M., Šentjurc, M., & Schara, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00044-0 · Cited by 163
Natural products against cancer: Review on phytochemicals from marine sources in preventing cancer
Wali, A. F., Majid, S., Rasool, S., Shehada, S. B., Abdulkareem, S. K., Firdous, A., Beigh, S., Shakeel, S., Mushtaq, S., Akbar, I., et al. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.04.013 · Cited by 158
Ren, S. X., Shen, J. S., Cheng, A. S. L., Lu, L., Chan, R. L. Y., Li, Z. J., Wang, X., Wong, C. C. M., Zhang, L., Ng, S. S. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063641 · Cited by 147
CAR T‐cell therapy for pancreatic cancer
DeSelm, C. J., Tano, Z. E., Varghese, A. M., & Adusumilli, P. S. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24627 · Cited by 119
Emerging strategies in cancer therapy combining chemotherapy with immunotherapy
Luo, Q., Zhang, L., Luo, C., & Jiang, M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.017 · Cited by 112
Marine natural products: Bryostatins in preclinical and clinical studies
Kollár, P., Rajchard, J., Balounová, Z., & Pazourek, J. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2013.804100 · Cited by 110
Lee, Y., Phat, C., & Hong, S. (2017) · Peptides · doi:10.1016/j.peptides.2017.06.002 · Cited by 110
Mollanoori, H., Shahraki, H., Rahmati, Y., & Teimourian, S. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.09.007 · Cited by 109
Kim, M., Kang, N. R., Ko, S. J., Park, J., Park, E., Shin, D. J., Kim, S. C., Lee, S., Lee, J., Lee, S., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103041 · Cited by 102
Protein S-palmitoylation and cancer
Yeste‐Velasco, M., Linder, M. E., & Lu, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.004 · Cited by 100
Pegylation and Its Impact on the Design of New Protein-Based Medicines
Ginn, C., Khalili, H., Lever, R., & Brocchini, S. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.125 · Cited by 96
Zhao, H., Yan, L., Xu, X., Jiang, C., Shi, J., Zhang, Y., Liu, L., Lei, S., Shao, D., & Huang, Q. (2018) · AMB Express · doi:10.1186/s13568-018-0606-3 · Cited by 95
Chen, Y., Mant, C. T., & Hodges, R. S. (2002) · Journal of Peptide Research · doi:10.1046/j.1397-002x.2001.10994.x · Cited by 94
Zagon, I. S., Donahue, R. N., & McLaughlin, P. J. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00414.2009 · Cited by 87
Beesoo, R., Neergheen, V. S., Bhagooli, R., & Bahorun, T. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.03.005 · Cited by 80
Yi, Z., Cho, S., Zhao, H., Wu, Y., Luo, J., Li, D., Yi, T., Xu, X., Wu, Z., & Liu, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.24027 · Cited by 77
Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics
Gaspar, D., Freire, J. M., Pacheco, T. R., Barata, J. T., & Castanho, M. A. R. B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.11.006 · Cited by 74
Cyclic depsipeptides as potential cancer therapeutics
Kitagaki, J., Shi, G., Miyauchi, S., Murakami, S., & Yang, Y. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000183 · Cited by 70
Self-citationThe interactions of aurein 1.2 with cancer cell membranes
Dennison, S. R., Harris, F., & Phoenix, D. A. (2006) · Biophysical Chemistry · doi:10.1016/j.bpc.2006.12.009 · Cited by 65
Ion channel regulation by protein S-acylation
Shipston, M. J. (2014) · The Journal of General Physiology · doi:10.1085/jgp.201411176 · Cited by 64
Bovine Lactoferrin Induces Cell Cycle Arrest and Inhibits Mtor Signaling in Breast Cancer Cells
Zhang, Y., Nicolau, A., Lima, C. F., & Rodrigues, L. R. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2014.956260 · Cited by 64
Targeting cancer cells via tumor-homing peptide CREKA functional PEG nanoparticles
Okur, A. C., Erkoc, P., & Kizilel, S. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.08.005 · Cited by 60
Cai, Z., Yin, Y., Shen, C., Wang, J., Yin, X., Chen, Z., Zhou, Y., & Zhang, B. (2018) · Surgical Oncology · doi:10.1016/j.suronc.2018.07.011 · Cited by 59
Expression and significance of CD47, PD1 and PDL1 in T-cell acute lymphoblastic lymphoma/leukemia
Yang, K. Y., Xu, J., Liu, Q., Li, J., & Xi, Y. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.10.021 · Cited by 55
Bae, S., Oh, K., Kim, H. M., Kim, Y., Kim, H., Hwang, Y., Lee, D., Kang, J. S., & Lee, W. J. (2013) · Immunobiology · doi:10.1016/j.imbio.2012.12.002 · Cited by 54
Wang, Y., Guo, D., He, J., Song, L., Chen, H., Zhang, Z., & Tan, N. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.088 · Cited by 48
Sanyal, A., Dutta, S., Camara, A., Chandran, A., Koller, A. A., Watson, B. G., Sengupta, R., Ysselstein, D., Montenegro, P., Cannon, J. R., et al. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.026 · Cited by 46
Research Progress Evaluating the Function and Mechanism of Anti-Tumor Peptides
Pan, X., Xu, J., & Jia, X. (2020) · Cancer Management and Research · doi:10.2147/cmar.s232708 · Cited by 46
Methionine enkephalin, its role in immunoregulation and cancer therapy
Zhao, D., Plotnikoff, N. P., Griffin, N., Song, T., & Shan, F. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.02.015 · Cited by 44
Hilchie, A. L., Vale, R., Zemlak, T., & Hoskin, D. W. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.07.006 · Cited by 43
Zhang, P., Ma, J., Zhang, Q., Jian, S., Sun, X., Liu, B., Nie, L., Liu, M., Liang, S., Zeng, Y., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00634 · Cited by 43
Han, Y., Liu, H., Han, D., Zong, X., Zhang, S., & Chen, Y. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.008 · Cited by 42
Pocheć, E., Lityń́ska, A., Bubka, M., Amoresano, A., & Casbarra, A. (2005) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.08.010 · Cited by 40
Li, X., Meng, Y., Plotnikoff, N. P., Youkilis, G., Griffin, N., Wang, E., Lu, C., & Shan, F. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2014.1003006 · Cited by 39
Domalaon, R., Findlay, B., Ogunsina, M. O., Arthur, G., & Schweizer, F. (2016) · Peptides · doi:10.1016/j.peptides.2016.07.007 · Cited by 39
Wang, C., Chen, Y.-W., Zhang, L., Gong, X.-G., Zhou, Y., & Shang, D. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1113539 · Cited by 38
Hayden, P. J., Sirait, T., Koster, L., Snowden, J. A., & Yakoub‐Agha, I. (2019) · Current Research in Translational Medicine · doi:10.1016/j.retram.2019.05.002 · Cited by 38
Activation of NF-κB by alloferon through down-regulation of antioxidant proteins and IκBα
Ryu, M., Anikin, V. B., Hong, S., Jeon, H., Yu, Y. G., Yu, M., Chernysh, S. I., & Lee, C. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9746-0 · Cited by 37
Aljabery, F. A.-S., Shabo, I., Gimm, O., Jahnson, S., & Olsson, H. (2018) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.05.025 · Cited by 28
A novel cyclic pentapeptide, H-10, inhibits B16 cancer cell growth and induces cell apoptosis
Zhang, G., Liu, S., Liu, Y., WANG, F., Ren, J., Gu, J., Zhou, K., & Shan, B. (2014) · Oncology Letters · doi:10.3892/ol.2014.2121 · Cited by 25
Li, S., Zou, R., Tu, Y., Wu, J., & Landry, M. P. (2017) · Chemical Science · doi:10.1039/c7sc02616a · Cited by 25
Expression de PD-L1 et inhibiteurs de la voie PD-1/PD-L1 dans le cancer du sein
Monneur, A., Gonçalvès, A., & Bertucci, F. (2018) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.11.012 · Cited by 24
Huang, C., Hsu, J., Chung, P.-H., Cheng, W. T.-K., Jiang, Y.-N., & Ju, Y. (2013) · Animal Biotechnology · doi:10.1080/10495398.2012.760469 · Cited by 20
A significantly enhanced antibacterial spectrum of D-enantiomeric lipopeptide bactenecin
Sim, J.-Y., Kim, S., Lee, J. H., Lim, H., Kim, H. H., Park, Z., & Kim, J. I. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.153 · Cited by 18
Kuroda, Y., Kato‐Kogoe, N., Tasaki, E., Yuasa‐Sunagawa, M., Yamanegi, K., Nakasyo, K., Nakase, I., Futaki, S., Tohyama, Y., & Hirose, M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.004 · Cited by 15
Bovine lactoferricin P13 triggers ROS-mediated caspase-dependent apoptosis in SMMC7721 cells
Meng, L., Xu, G., Li, J., Liu, W., Jia, W., Ma, J., & Wei, D. (2016) · Oncology Letters · doi:10.3892/ol.2016.5415 · Cited by 12
-Amino acid mutation of PMI as potent dual peptide inhibitors of p53-MDM2/MDMX interactions
Li, X., Liu, C., Chen, S., Hu, H., Su, J., & Zou, Y. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.09.014 · Cited by 10
Han, L., Tang, L., Jiang, Z., & Jiang, Y. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.05.009 · Cited by 7
Cited by
Bridging machine learning and peptide design for cancer treatment: a comprehensive review
Rezaee, K., & Eslami, H. (2025) · Artificial Intelligence Review · doi:10.1007/s10462-025-11148-3 · Cited by 34
Metadata
- Authors
- Xie, M., Liu, D., & Yang, Y.
- Venue
- Open Biology
- Publisher
- The Royal Society
- Published
- 2020-07
- Volume
- 10
- Issue
- 7
- Pages
- 200004-200004
- ISSN
- 2046-2441 (ISSN-L)
- OpenAlex
- W3044216590
- Cited by
- 272
- References
- 70
- FWCI
- 17.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.